Literature DB >> 33462610

Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.

Jill M Ferdinands1, Manjusha Gaglani2, Emily T Martin3, Arnold S Monto3, Donald Middleton4, Fernanda Silveira4, H Keipp Talbot5, Richard Zimmerman4, Manish Patel1.   

Abstract

We observed decreased effectiveness of influenza vaccine with increasing time since vaccination for prevention of influenza A(H3N2), influenza A(H1N1)pdm09, and influenza B/Yamagata-associated hospitalizations among adults. Maximum vaccine effectiveness (VE) was observed shortly after vaccination, followed by an absolute decline in VE of about 8%-9% per month postvaccination. Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Entities:  

Keywords:  adults; hospitalization; influenza; vaccine effectiveness; waning

Mesh：

Substances：

Year:  2021        PMID： 33462610      PMCID： PMC8499703          DOI： 10.1093/cid/ciab045

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Immunity in Human Subjects Artificially Infected with Influenza Virus, Type B.

Authors:  T Francis; H E Pearson; J E Salk; P N Brown
Journal:  Am J Public Health Nations Health       Date:  1944-04

2.  Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

Authors:  Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Don Middleton; Arnold S Monto; Kempapura Murthy; Fernanda P Silveira; H Keipp Talbot; Richard Zimmerman; Elif Alyanak; Courtney Strickland; Sarah Spencer; Alicia M Fry
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

3.  Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.

Authors:  L K Durham; I M Longini; M E Halloran; J D Clemens; A Nizam; M Rao
Journal:  Am J Epidemiol       Date:  1998-05-15       Impact factor: 4.897

4.  Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults.

Authors:  Jill M Ferdinands; Elif Alyanak; Carrie Reed; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

5.  Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.

Authors:  Jill M Ferdinands; Alicia M Fry; Sue Reynolds; Joshua Petrie; Brendan Flannery; Michael L Jackson; Edward A Belongia
Journal:  Clin Infect Dis       Date:  2016-12-29       Impact factor: 9.079

6.  Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.

Authors:  Barnaby Young; Sapna Sadarangani; Lili Jiang; Annelies Wilder-Smith; Mark I-Cheng Chen
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

7.  Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season.

Authors:  Edward A Belongia; Maria E Sundaram; David L McClure; Jennifer K Meece; Jill Ferdinands; Jeffrey J VanWormer
Journal:  Vaccine       Date:  2014-06-21       Impact factor: 3.641

8.  Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.

Authors:  Joshua G Petrie; Suzanne E Ohmit; Rachel Truscon; Emileigh Johnson; Thomas M Braun; Min Z Levine; Maryna C Eichelberger; Arnold S Monto
Journal:  J Infect Dis       Date:  2016-04-19       Impact factor: 5.226

9.  Waning of Measured Influenza Vaccine Effectiveness Over Time: The Potential Contribution of Leaky Vaccine Effect.

Authors:  Jerome I Tokars; Manish M Patel; Ivo M Foppa; Carrie Reed; Alicia M Fry; Jill M Ferdinands
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

10.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

Authors:  Lisa A Grohskopf; Elif Alyanak; Karen R Broder; Emmanuel B Walter; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2019-08-23
View more
  6 in total

1.  Waning Vaccine Protection against Influenza among Department of Defense Adult Beneficiaries in the United States, 2016-2017 through 2019-2020 Influenza Seasons.

Authors:  Wenping Hu; Paul A Sjoberg; Anthony C Fries; Laurie S DeMarcus; Anthony S Robbins
Journal:  Vaccines (Basel)       Date:  2022-06-01

2.  Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.

Authors:  Mark W Tenforde; Wesley H Self; Eric A Naioti; Adit A Ginde; David J Douin; Samantha M Olson; H Keipp Talbot; Jonathan D Casey; Nicholas M Mohr; Anne Zepeski; Manjusha Gaglani; Tresa McNeal; Shekhar Ghamande; Nathan I Shapiro; Kevin W Gibbs; D Clark Files; David N Hager; Arber Shehu; Matthew E Prekker; Heidi L Erickson; Michelle N Gong; Amira Mohamed; Daniel J Henning; Jay S Steingrub; Ithan D Peltan; Samuel M Brown; Emily T Martin; Arnold S Monto; Akram Khan; Catherine L Hough; Laurence W Busse; Caitlin C Ten Lohuis; Abhijit Duggal; Jennifer G Wilson; Alexandra June Gordon; Nida Qadir; Steven Y Chang; Christopher Mallow; Carolina Rivas; Hilary M Babcock; Jennie H Kwon; Matthew C Exline; Natasha Halasa; James D Chappell; Adam S Lauring; Carlos G Grijalva; Todd W Rice; Ian D Jones; William B Stubblefield; Adrienne Baughman; Kelsey N Womack; Christopher J Lindsell; Kimberly W Hart; Yuwei Zhu; Meagan Stephenson; Stephanie J Schrag; Miwako Kobayashi; Jennifer R Verani; Manish M Patel
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-08-27       Impact factor: 35.301

3.  A comparative analysis of the epidemiology of influenza and respiratory syncytial virus in Russia, 2013/14 to 2018/19.

Authors:  Saverio Caini; Kirill Stolyarov; Anna Sominina; Elizaveta Smorodintseva; Lisa Staadegaard; John Paget; Daria Danilenko
Journal:  J Glob Health       Date:  2022-02-05       Impact factor: 4.413

4.  Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology.

Authors:  Martina E McMenamin; Helen S Bond; Sheena G Sullivan; Benjamin J Cowling
Journal:  Epidemiology       Date:  2022-05-01       Impact factor: 4.822

Review 5.  Influenza.

Authors:  Timothy M Uyeki; David S Hui; Maria Zambon; David E Wentworth; Arnold S Monto
Journal:  Lancet       Date:  2022-08-27       Impact factor: 202.731

6.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.

Authors:  Lisa A Grohskopf; Lenee H Blanton; Jill M Ferdinands; Jessie R Chung; Karen R Broder; H Keipp Talbot; Rebecca L Morgan; Alicia M Fry
Journal:  MMWR Recomm Rep       Date:  2022-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.